JP2005506947A5 - - Google Patents

Download PDF

Info

Publication number
JP2005506947A5
JP2005506947A5 JP2000593637A JP2000593637A JP2005506947A5 JP 2005506947 A5 JP2005506947 A5 JP 2005506947A5 JP 2000593637 A JP2000593637 A JP 2000593637A JP 2000593637 A JP2000593637 A JP 2000593637A JP 2005506947 A5 JP2005506947 A5 JP 2005506947A5
Authority
JP
Japan
Prior art keywords
compound
formula
xix
xiv
xiii
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2000593637A
Other languages
English (en)
Japanese (ja)
Other versions
JP2005506947A (ja
JP4712975B2 (ja
Filing date
Publication date
Priority claimed from US09/452,406 external-priority patent/US7238711B1/en
Application filed filed Critical
Priority claimed from PCT/US2000/000821 external-priority patent/WO2000042071A2/en
Publication of JP2005506947A publication Critical patent/JP2005506947A/ja
Publication of JP2005506947A5 publication Critical patent/JP2005506947A5/ja
Application granted granted Critical
Publication of JP4712975B2 publication Critical patent/JP4712975B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2000593637A 1999-01-12 2000-01-12 炎症反応を阻害又は増強するための組成物及び方法 Expired - Fee Related JP4712975B2 (ja)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US22907199A 1999-01-12 1999-01-12
US09/229,071 1999-01-12
US27119299A 1999-03-17 1999-03-17
US09/271,192 1999-03-17
US09/452,406 1999-12-01
US09/452,406 US7238711B1 (en) 1999-03-17 1999-12-01 Compounds and methods to inhibit or augment an inflammatory response
PCT/US2000/000821 WO2000042071A2 (en) 1999-01-12 2000-01-12 Compounds and methods to inhibit or augment an inflammatory response

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2010043809A Division JP5351078B2 (ja) 1999-01-12 2010-03-01 炎症反応を阻害又は増強するための組成物及び方法

Publications (3)

Publication Number Publication Date
JP2005506947A JP2005506947A (ja) 2005-03-10
JP2005506947A5 true JP2005506947A5 (enExample) 2006-01-05
JP4712975B2 JP4712975B2 (ja) 2011-06-29

Family

ID=27397912

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2000593637A Expired - Fee Related JP4712975B2 (ja) 1999-01-12 2000-01-12 炎症反応を阻害又は増強するための組成物及び方法
JP2010043809A Expired - Fee Related JP5351078B2 (ja) 1999-01-12 2010-03-01 炎症反応を阻害又は増強するための組成物及び方法

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2010043809A Expired - Fee Related JP5351078B2 (ja) 1999-01-12 2010-03-01 炎症反応を阻害又は増強するための組成物及び方法

Country Status (6)

Country Link
EP (2) EP1141011A2 (enExample)
JP (2) JP4712975B2 (enExample)
AU (1) AU2610000A (enExample)
CA (2) CA2363067C (enExample)
HK (1) HK1039784A1 (enExample)
WO (1) WO2000042071A2 (enExample)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2002537362A (ja) * 1999-02-22 2002-11-05 ミレニアム・ファーマシューティカルズ・インコーポレイテッド ビオチン化ケモカイン抗体複合体
US6869606B1 (en) 1999-02-22 2005-03-22 Millennium Pharmaceuticals, Inc. Biotinylated-chemokine antibody complexes
AR035773A1 (es) 2000-12-20 2004-07-14 Bristol Myers Squibb Pharma Co Compuestos diamino ciclico, composicion farmaceutica y su uso en la fabricacion de un medicamento util para modular la actividad de una quimioquina
CA2432908A1 (en) 2000-12-20 2002-06-27 Bristol-Myers Squibb Pharma Company Diamines as modulators of chemokine receptor activity
DE102004054421B4 (de) * 2003-11-12 2019-06-27 Ajinomoto Co., Inc. Geliermittel für Öl
JP5248779B2 (ja) 2003-12-01 2013-07-31 ケンブリッジ エンタープライズ リミティド 抗炎症剤
RU2267496C2 (ru) 2004-01-15 2006-01-10 Сергей Иванович Черныш Противоопухолевые и антивирусные пептиды
GB2418426A (en) 2004-08-18 2006-03-29 Univ Cambridge Tech Alpha-(acylamino)-bicyclolactam derivatives for treatment of inflammatory disorders
GB2418427A (en) 2004-09-02 2006-03-29 Univ Cambridge Tech Ligands for G-protein coupled receptors
GB0511060D0 (en) 2005-05-31 2005-07-06 Novartis Ag Organic compounds
GB0512238D0 (en) 2005-06-15 2005-07-27 Univ Cambridge Tech Anti-inflammatory agents
WO2007021807A1 (en) 2005-08-12 2007-02-22 Schering Corporation Mcp1 fusions
WO2008084478A2 (en) * 2007-01-09 2008-07-17 Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. Anti-bacterial peptides and methods of treating diseases using same
GB2452696B (en) 2007-08-02 2009-09-23 Cambridge Entpr Ltd 3-(2',2'-dimethylpropanoylamino)-tetrahydropyridin-2-one and its use in pharmaceutical compositions
GB2455539B (en) * 2007-12-12 2012-01-18 Cambridge Entpr Ltd Anti-inflammatory compositions and combinations
EP3744729B1 (en) 2009-01-16 2023-03-01 Sederma Peptides, compositions comprising them and cosmetic and dermopharmaceutical uses
FR2941232B1 (fr) * 2009-01-16 2014-08-08 Sederma Sa Nouveaux peptides, compositions les comprenant et utilisations cosmetiques et dermo-pharmaceutiques.
FR2941231B1 (fr) * 2009-01-16 2016-04-01 Sederma Sa Nouveaux peptides, compositions les comprenant et utilisations cosmetiques et dermo-pharmaceutiques.
US8524217B2 (en) 2010-05-11 2013-09-03 Merck Sharp & Dohme Corp. MCP1-Ig fusion variants
GB201009603D0 (en) 2010-06-08 2010-07-21 Cambridge Entpr Ltd Anti-inflammatory agent
CN102795977A (zh) * 2012-08-27 2012-11-28 昆明博鸿生物科技有限公司 一种(7z,11z,13e)-十六碳三烯醛的合成方法
US9180203B2 (en) * 2012-10-23 2015-11-10 The Johns Hopkins University Self-assembling drug amphiphiles and methods for synthesis and use
WO2014148136A1 (ja) * 2013-03-19 2014-09-25 岐阜市 抗アレルギー活性化合物及びその用途
ITRM20130199A1 (it) 2013-04-03 2014-10-04 Irbm Science Park S P A Peptidi per uso dermatologico e/o cosmetico
JP6856532B2 (ja) * 2015-01-20 2021-04-07 エックスオーシー ファーマシューティカルズ インコーポレイテッドＸｏｃ Ｐｈａｒｍａｃｅｕｔｉｃａｌｓ， Ｉｎｃ エルゴリン化合物およびその使用
CN109153644B (zh) 2016-03-16 2022-10-21 H·李·莫菲特癌症中心研究有限公司 用以增强效应t细胞功能的针对cereblon的小分子
CA3064274A1 (en) 2017-06-01 2018-12-06 Xoc Pharmaceuticals, Inc. Ergoline derivatives for use in medicine
EP3820532A4 (en) 2018-07-11 2022-04-06 H. Lee Moffitt Cancer Center & Research Institute, Inc. DIMERE IMMUNOMODULATORY COMPOUNDS AGAINST CEREBLON-BASED MECHANISMS
IT202000025423A1 (it) * 2020-10-27 2022-04-27 Ulisse Biomed S P A Uso di proteine per il trattamento di patologie associate a tossine formanti pori o a proteine virali
US20250255934A1 (en) * 2021-05-07 2025-08-14 Lateral IP Pty Ltd Compositions for treating inflammatory airway disease and uses thereof

Family Cites Families (62)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2857386A (en) * 1956-04-09 1958-10-21 Ciba Pharm Prod Inc Iso reserpic and iso deserpidic acids, salts and esters
US3119819A (en) * 1959-07-29 1964-01-28 Ciba Geigy Corp Intermediates for 18-o-alkyl-reserpic acid esters and related compounds
FR1451176A (fr) * 1962-01-11 1966-01-07 Procédé de préparation de dérivés de l'acide nicotinique des acides alpha-amino-carboxyliques
US3291800A (en) * 1963-07-23 1966-12-13 Warner Lambert Pharmaceutical 3-substituted derivatives of yohimbane alkaloids and process for their production
US3264303A (en) * 1964-04-06 1966-08-02 Ciba Geigy Corp Process for the manufacture of yohimbane-18-omicron-ethers
US4093709A (en) 1975-01-28 1978-06-06 Alza Corporation Drug delivery devices manufactured from poly(orthoesters) and poly(orthocarbonates)
US4051842A (en) 1975-09-15 1977-10-04 International Medical Corporation Electrode and interfacing pad for electrical physiological systems
HU172479B (hu) * 1976-03-09 1978-09-28 Gyogyszerkutato Intezet Sposob poluchenija novykh soedinenij s ehrgolenovymi i
DE2626348C3 (de) 1976-06-11 1980-01-31 Siemens Ag, 1000 Berlin Und 8000 Muenchen Implantierbare Dosiereinrichtung
NO812612L (no) 1980-08-06 1982-02-08 Ferring Pharma Ltd Enzym-inhibitorer.
US4383529A (en) 1980-11-03 1983-05-17 Wescor, Inc. Iontophoretic electrode device, method and gel insert
US4675189A (en) 1980-11-18 1987-06-23 Syntex (U.S.A.) Inc. Microencapsulation of water soluble active polypeptides
US4525359A (en) * 1982-12-10 1985-06-25 Greenway Frank L Iii Treatment for selective weight control
US5120526A (en) 1985-01-14 1992-06-09 Neorx Corporation Method of producing metal radionuclide labeled proteins for diagnosis and therapy
US4897255A (en) 1985-01-14 1990-01-30 Neorx Corporation Metal radionuclide labeled proteins for diagnosis and therapy
US5175343A (en) 1985-01-14 1992-12-29 Neorx Corporation Metal radionuclide labeled proteins for diagnosis and therapy
WO1986004334A1 (en) * 1985-01-18 1986-07-31 MERCK Patent Gesellschaft mit beschränkter Haftung Immunoregulatory peptides
JPS62501502A (ja) * 1985-01-18 1987-06-18 イミユーンテツク・フアーマシユーテイカルズ 免疫調節性ペプチド
US4683195A (en) 1986-01-30 1987-07-28 Cetus Corporation Process for amplifying, detecting, and/or-cloning nucleic acid sequences
US5045303A (en) 1985-05-17 1991-09-03 Neorx Corporation Radiohalogenated small molecules for protein labeling
US4877868A (en) 1986-03-12 1989-10-31 Neorx Corporation Radionuclide antibody coupling
US5560922A (en) 1986-05-30 1996-10-01 Rutgers, The State University Of New Jersey Transdermal absorption dosage unit using a polyacrylate adhesive polymer and process
US4879225A (en) 1986-06-20 1989-11-07 Neorx Corporation Enhanced production of antibodies utilizing insolubilized immune complexes
US4863713A (en) 1986-06-23 1989-09-05 The Board Of Trustees Of Leland Stanford Jr. Univ. Method and system for administering therapeutic and diagnostic agents
US5202118A (en) 1987-12-18 1993-04-13 Immunex Corporation Method for promoting wound healing using IL-1
US5091396A (en) 1988-07-20 1992-02-25 Monsanto Co. Pyridyl peptide mimetic compounds which are useful platelet-aggregation inhibitors
US4992463A (en) 1988-07-20 1991-02-12 Monsanto Company Thienyl peptide mimetic compounds which are useful in inhibiting platelet aggregation
GB8823869D0 (en) 1988-10-12 1988-11-16 Medical Res Council Production of antibodies
US5028594A (en) * 1988-12-27 1991-07-02 Naxcor Use of photodynamic compositions for cytotoxic effects
US5703055A (en) 1989-03-21 1997-12-30 Wisconsin Alumni Research Foundation Generation of antibodies through lipid mediated DNA delivery
US5580774A (en) 1989-07-31 1996-12-03 Eli Lilly And Company Chimeric antibodies directed against a human glycoprotein antigen
US5661132A (en) 1989-12-14 1997-08-26 Auragen, Inc. Wound healing
US5545806A (en) 1990-08-29 1996-08-13 Genpharm International, Inc. Ransgenic non-human animals for producing heterologous antibodies
ES2246502T3 (es) 1990-08-29 2006-02-16 Genpharm International, Inc. Animales no humanos transgenicos capaces de producir anticuerpos heterologos.
US5625126A (en) 1990-08-29 1997-04-29 Genpharm International, Inc. Transgenic non-human animals for producing heterologous antibodies
US5650150A (en) 1990-11-09 1997-07-22 Gillies; Stephen D. Recombinant antibody cytokine fusion proteins
US5824647A (en) * 1990-12-12 1998-10-20 Postlethwaite; Arnold E. Chemotactic wound healing peptides
US5202169A (en) 1991-01-23 1993-04-13 Spendlove Max J Releasable fastener, method of releasably fastening, and releasable fastener dispenser
CA2113990A1 (en) 1991-07-26 1993-02-18 Frederick L. Moolten Cancer therapy utilizing malignant cells
US5326752A (en) * 1991-11-27 1994-07-05 Glycomed Incorporated Substituted lactose and lactosamine derivatives as cell adhesion inhibitors
US5624896A (en) 1992-06-09 1997-04-29 Neorx Corporation Clearing agents useful in pretargeting methods
US5578287A (en) 1992-06-09 1996-11-26 Neorx Corporation Three-step pretargeting methods using improved biotin-active agent
US5616690A (en) 1992-06-09 1997-04-01 Neorx Corporation Hexose derivatized human serum albumin clearing agents
CA2134239C (en) 1992-06-09 2004-11-23 Donald B. Axworthy Pretargeting methods and compounds
WO1996040098A2 (en) 1995-06-07 1996-12-19 Neorx Corporation Prevention and treatment of cardiovascular pathologies with tamoxifen analogues
EP0710243B1 (en) 1993-06-29 2000-06-14 Ferring B.V. Synthesis of cyclic peptides
JPH09505555A (ja) * 1993-08-13 1997-06-03 ザ ガバメント オブ ザ ユナイテッド ステイツ オブ アメリカ，アズ リプレゼンテッド バイ ザ セクレタリー，デパートメント オブ ヘルス アンド ヒューマン サービシーズ ＴＧＦ−βの活性を刺激および阻害する方法および組成物
US5459128A (en) * 1993-11-12 1995-10-17 Dana-Farber Cancer Institute Human monocyte chemoattractant protein-1 (MCP-1) derivatives
CA2178477A1 (en) 1993-12-07 1995-06-15 Louis J. Theodore Pretargeting methods and compounds
US5708163A (en) 1994-03-15 1998-01-13 Sloan-Kettering Institute Of Cancer Research Synthesis of the breast tumor-associated antigen defined by monoclonalantibody MBRL and uses thereof
US6303120B1 (en) 1994-03-15 2001-10-16 Memorial Sloan-Kettering Institute For Cancer Research Synthesis of glycoconjugates of the lewis y epitope and uses thereof
JP3447809B2 (ja) * 1994-07-12 2003-09-16 花王株式会社 浴用剤
WO1996029074A1 (en) * 1995-03-22 1996-09-26 Eli Lilly And Company Methods of treating or preventing pain or nociception
US6265184B1 (en) 1995-12-20 2001-07-24 Icos Corporation Polynucleotides encoding chemokine receptor 88C
WO1997029192A1 (en) 1996-02-12 1997-08-14 Schering Corporation Mammalian dendritic cell chemokine reagents
US5667894A (en) 1996-06-05 1997-09-16 E. I. Du Pont De Nemours And Company Cathodic electrocoating compositions containing methane sulfonic acid as a neutralizing agent
GB9617923D0 (en) 1996-08-28 1996-10-09 Smithkline Beecham Plc Novel receptor
US5848956A (en) 1997-03-18 1998-12-15 Grettner; Norman L. Multi-purpose lat sling
US6214540B1 (en) * 1997-03-26 2001-04-10 University Of Maryland Biotechnology Institute Chemokines that inhibit immunodeficiency virus infection and methods based thereon
AU7583998A (en) 1997-05-29 1998-12-30 Zymogenetics Inc. Human chemokine zchemo-8
US6989435B2 (en) * 1997-09-11 2006-01-24 Cambridge University Technical Services Ltd. Compounds and methods to inhibit or augment an inflammatory response
US5807482A (en) * 1997-10-31 1998-09-15 Uop Llc Chiral stationary phase based on yohimbinic acid

Similar Documents

Publication Publication Date Title
CA2363067A1 (en) Compounds and methods to inhibit or augment an inflammatory response
US8524229B2 (en) Medicament and a method for regulation of the vascular tone
JP4574007B2 (ja) ポリオール−ｉｆｎ−ベータ複体
USRE39055E1 (en) Hepatoselective pharmaceutical actives
DE69434725T2 (de) Zell- und Serumproteinanker und Konjugate
AU2004216823B2 (en) Pharmaceutical preparations containing thiazolidinediones for the treatment or prevention of IP-10 mediated diseases
KR20010079669A (ko) 기질 활성의 조절
IL112427A (en) Production of pharmaceutical compositions comprising anti-tnf antibodies
JP2001514222A (ja) アムロジピン及びアトルバスタチンを含む治療用の組み合わせ
CA2352765A1 (en) Hapten-carrier conjugates for treating and preventing nicotine addiction
JP2001506609A (ja) 生理活性の増加した多量体エリスロポエチン
KR101058467B1 (ko) 부신피질 자극 호르몬 유사체 및 관련 방법
US20090186040A1 (en) DOSING METHODS FOR TREATING AUTOIMMUNE DISEASES USING A TACI-Ig FUSION PROTEIN SUCH AS ATACICEPT
EP1154799A2 (en) Biotinylated-chemokine antibody complexes
JPH03503632A (ja) 血液脳関門を経る治療薬の分別送達
JP2002538170A5 (enExample)
Herdman et al. Anticoagulants in renal disease in children
US9084761B2 (en) Use of interleukin-15 to treat cardiovascular diseases
EP1845987A2 (en) Treatment of inflammatory disorders with praziquantel
Goulding et al. Increase in neutrophil Fc gamma receptor I expression following interferon gamma treatment in rheumatoid arthritis.
EA006881B1 (ru) ПРИМЕНЕНИЕ АКТИВАТОРОВ gp130 ПРИ ДИАБЕТИЧЕСКОЙ НЕВРОПАТИИ
JP2006511468A (ja) 内因性エリスロポエチンの組織保護活性を維持する長期作用性エリスロポエチン
CA1341425C (en) Antibodies to angiogenin: immunotherapeutic agents
CN1638807B (zh) 在预靶向的放射免疫治疗中有效增加放射性生物素浓度的抗生物素蛋白二聚体
JPH09151137A (ja) 平滑筋細胞増殖抑制剤